ArticleAmerican journal of translational research2025
Antimicrobial drug-derived carbon quantum dots for photodynamic therapy of bedsores and bacterial infections.
Article in American journal of translational research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectivesBedsores (pressure ulcers) exhibit high incidence rates (0.4-38%) and prolonged recovery periods, with bacterial infections posing the most frequent and severe complications, significantly impeding wound healing. Conventional antibiotic therapies face limitations due to antimicrobial resistance, necessitating innovative strategies with enhanced biocompatibility and reduced resistance-inducing potential. This study aimed to develop a photodynamic therapy (PDT)-based antimicrobial approach by converting antimicrobial drugs into N-doped carbon quantum dots (N, CQ-dots) for efficient bacterial inhibition in wound environments.
methodsN, CQ-dots were synthesized from protocatechuic acid (a natural antimicrobial metabolite) via solvothermal method, preserving critical functional groups (-COOH, -OH) inherited from the precursor. Structural and optical properties were characterized using transmission electron microscopy (TEM), X-ray photoelectron spectroscopy (XPS), and ultraviolet-to-visible (UV-Vis) spectroscopy. Photodynamic antimicrobial efficacy was evaluated against Staphylococcus aureus and Escherichia coli through colony-count assays, and live/dead staining.
resultsThe synthesized N, CQ-dots exhibited uniform morphology (~3.5 nm) and abundant oxygen-containing functional groups, as confirmed by XPS and Fourier Transform Infrared (FTIR) spectrometer analysis. Under irradiation, the material demonstrated potent antibacterial activity, achieving >99.9% viability reduction in Gram-positive and Gram-negative strains, with minimal cytotoxicity (MBC >100 μg/mL).
conclusionsThis work demonstrates a novel paradigm for transforming antimicrobial drugs into multifunctional N, CQ-dots, leveraging preserved pharmacophores and PDT mechanisms to overcome drug resistance. The system combines intrinsic antibacterial activity with light-triggered responsiveness, offering a promising solution for managing infected bedsores while minimizing systemic toxicity. These findings highlight the translational potential of drug-derived nanomaterials in precision wound care.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.